Abiopharma

ADICET BIO, INC. (ACET)

Symbol	ACET
Name	ADICET BIO, INC.
Sector	HEALTH CARE
Region	North America
Industry	Biotechnology: Pharmaceutical Preparations
Address	200 CLARENDON STREET,FLOOR 6, BOSTON, Massachusetts, 02116, United States
Telephone	+1 650 503-9095
Fax	—
Email	—
Website	https://www.adicetbio.com
Incorporation	UNDEFINED
Incorporated On	—
Employees	—
Fiscal Year	—
Public Since	—
Exchanges	NASDAQ
Auditor	—
Audit Status	NOT PROVIDED
Reporting Status	—
CIK	0001720580
Description	Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. The company is advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and improve persistence for durable activity in patients. Additional info from NASDAQ: Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. The company is advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and improve persistence for durable activity in patients.

2026-07-21 20:00

Adicet Bio to Participate in Fireside Chat at Canaccord Genuity 46th Annual Growth Conference

2026-06-23 22:51

Schor Chen 🟢 acquired 55.0K shares (1 derivative) of Adicet Bio, Inc. (ACET) at $8.10 Transaction Date: Jun 19, 2026 | Filing ID: 000007

2026-06-23 22:49

Aftab Blake 🟢 acquired 55.0K shares (1 derivative) of Adicet Bio, Inc. (ACET) at $8.10 Transaction Date: Jun 19, 2026 | Filing ID: 000004

2026-06-23 20:31

DUBIN STEVE 🟢 acquired 4.2K shares (1 derivative) of Adicet Bio, Inc. (ACET) at $8.10 Transaction Date: Jun 21, 2026 | Filing ID: 000001

2026-06-23 20:30

Chodakewitz Jeffrey 🟢 acquired 4.2K shares (1 derivative) of Adicet Bio, Inc. (ACET) at $8.10 Transaction Date: Jun 21, 2026 | Filing ID: 000002

2026-06-23 20:29

Grissinger Michael 🟢 acquired 4.2K shares (1 derivative) of Adicet Bio, Inc. (ACET) at $8.10 Transaction Date: Jun 21, 2026 | Filing ID: 000002

2026-06-23 20:27

Sinclair Andrew 🟢 acquired 4.2K shares (1 derivative) of Adicet Bio, Inc. (ACET) at $8.10 Transaction Date: Jun 21, 2026 | Filing ID: 000002

2026-06-23 20:26

Peng Katie 🟢 acquired 4.2K shares (1 derivative) of Adicet Bio, Inc. (ACET) at $8.10 Transaction Date: Jun 21, 2026 | Filing ID: 000001

2026-06-23 20:25

Klickstein Lloyd 🟢 acquired 4.2K shares (1 derivative) of Adicet Bio, Inc. (ACET) at $8.10 Transaction Date: Jun 21, 2026 | Filing ID: 000001

2026-05-15 10:11

New Form SCHEDULE 13G/A - Adicet Bio, Inc. Filed: 2026-05-15 AccNo: 0000919574-26-003239 Size: 9 KB

No clinical trials found for this company.

No clinical products found for this company.